人格障碍

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013.

Hahn SR, Thompson KS, Wills TA, et al. The difficult doctor-patient relationship: somatization, personality and psychopathology. J Clin Epidemiol. 1994 Jun;47(6):647-57.

• 摘要

Devens M. Personality disorders. Prim Care. 2007 Sep;34(3):623-40.

• 摘要

Paris J. Clinical trials of treatment for personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):517-26.

• 摘要

Hadjipavlou G, Ogrodniczuk JS. Promising psychotherapies for personality disorders. Can J Psychiatry. 2010 Apr;55(4):202-10.

• 摘要

Madeddu F, Aquaro P, Preti E. Psychotherapy for borderline personality disorder: A review of literature on the efficacy of four manualized treatments [in Italian]. Italian J Psychopathol. 2012;18(3):196-209.

• 全文

Stoffers JM, Völlm BA, Rücker G, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD005652.

• 全文
• 摘要

Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.

• 全文
• 摘要

Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007;8(4):212-44.

• 全文
• 摘要

Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011 Aug;68(8):827-37.

• 全文
• 摘要

1.  American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013.

2.  Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970 Jan;126(7):983-7.

• 摘要

3.  Lenzenweger M. The longitudinal study of personality disorders: history, design considerations, and initial findings. J Pers Dis. 2006 Dec;20(6):645-70.

• 摘要

4.  Bajaj P, Tyrer P. Managing mood disorders and comorbid personality disorders. Curr Opin Psychiatry. 2005 Jan;18(1):27-31.

• 摘要

5.  Gunderson J, Weinberg I, Daversa M, et al. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006 Jul;163(7):1173-8.

• 摘要

6.  Oldham JM, Skodol AE, Kellman HD, et al. Comorbidity of axis I and axis II disorders. Am J Psychiatry. 1995 Apr;152(4):571-8.

• 摘要

7.  World Health Organization. International statistical classification of diseases and related health problems, 10th revision: ICD-10. 2010 [internet publication].

• 全文

8.  Samuels J, Eaton WW, Bienvenu OJ 3rd, et al. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry. 2002 Jun;180(6):536-42.

• 全文
• 摘要

9.  Crawford T, Cohen P, Johnson J, et al. Self-reported personality disorder in the children in the community sample: convergent and prospective validity in late adolescence and adulthood. J Pers Disord. 2005 Feb;19(1):30-52.

• 摘要

10.  Grant B, Hasin D, Stinson F, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004 Jul;65(7):948-58.

• 摘要

11.  Trull TJ, Jahng S, Tomko RL, et al. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010 Aug;24(4):412-26.

• 摘要

12.  Lenzenweger MF, Lane MC, Loranger AW, et al. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Sep 15;62(6):553-64.

• 全文
• 摘要

13.  Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001 Jun;58(6):590-6.

• 摘要

14.  Coid J, Yang M, Tyrer P, et al. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006 May;188(5):423-31.

• 全文
• 摘要

15.  McGilloway A, Hall RE, Lee T, et al. A systematic review of personality disorder, race and ethnicity: prevalence, aetiology and treatment. BMC Psychiatry. 2010 May 11;10:33.

• 摘要

16.  Reichborn-Kjennerud T. Genetics of personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):421-40.

• 摘要

17.  Rhee S, Waldman I. Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol Bull. 2002 May;128(3):490-529.

• 摘要

18.  Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry. 2000 Nov-Dec;41(6):416-25.

• 摘要

19.  Bradley R, Jenei J, Westen D. Etiology of borderline personality disorder: disentangling the contributions of intercorrelated antecedents. J Nerv Ment Dis. 2005 Jan;193(1):24-31.

• 摘要

20.  Coolidge F, Thede L, Jang K. Heritability of personality disorders in childhood: a preliminary investigation. J Pers Disord. 2001 Feb;15(1):33-40.

• 摘要

21.  Reichborn-Kjennerud T, Czajkowski N, Neale MC, et al. Genetic and environmental influences on dimensional representations of DSM-IV cluster C personality disorders: a population-based multivariate twin study. Psychol Med. 2007 May;37(5):645-53.

• 摘要

22.  Reichborn-Kjennerud T, Czajkowski N, Ystrøm E, et al. A longitudinal twin study of borderline and antisocial personality disorder traits in early to middle adulthood. Psychol Med. 2015 Oct;45(14):3121-31.

• 摘要

23.  Kaffman A, Meaney MJ. Neurodevelopmental sequelae of postnatal maternal care in rodents: clinical and research implications of molecular insights. J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):224-44.

• 摘要

24.  Martín-Blanco A, Ferrer M, Soler J, et al. The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder. Eur Arch Psychiatry Clin Neurosci. 2016 Jun;266(4):307-16.

• 摘要

25.  Essex MJ, Klein MH, Cho E, et al. Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on cortisol and behavior. Biol Psychiatry. 2002 Oct 15;52(8):776-84.

• 摘要

26.  Winsper C, Wolke D, Lereya T. Prospective associations between prenatal adversities and borderline personality disorder at 11-12 years. Psychol Med. 2015 Apr;45(5):1025-37.

• 摘要

27.  Johnson JG, Cohen P, Brown J, et al. Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry. 1999 Jul;56(7):600-6.

• 全文
• 摘要

28.  Eikenaes I, Egeland J, Hummelen B, et al. Avoidant personality disorder versus social phobia: the significance of childhood neglect. PLoS One. 2015 Mar 27;10(3):e0122846.

• 全文
• 摘要

29.  Spatz Widom C, Czaja SJ, Paris J. A prospective investigation of borderline personality disorder in abused and neglected children followed up into adulthood. J Pers Disord. 2009 Oct;23(5):433-46.

• 摘要

30.  Jang K, Dick D, Wolf H, et al. Psychosocial adversity and emotional instability: an application of gene-environment interaction models. Eur J Pers. 2005 Jun;19(4):359-72.

• 全文

31.  Brent DA, Melhem N. Familial transmission of suicidal behavior. Psychiatr Clin North Am. 2008 Jun;31(2):157-77.

• 全文
• 摘要

32.  Mittal VA, Dhruv S, Tessner KD, et al. The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol. Biol Psychiatry. 2007 May 15;61(10):1179-86.

• 摘要

33.  New AS, Goodman M, Tribwasser J, et al. Recent advances in the biological study of personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):441-61,vii.

• 摘要

34.  Johnson PA, Hurley RA, Benkelfat C, et al. Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging. J Neuropsychiatry Clin Neurosci. 2003 Fall;15(4):397-402.

• 摘要

35.  Friedel RO. Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacol. 2004 Jun;29(6):1029-39.

• 摘要

36.  Herpertz SC, Bertsch K. A new perspective on the pathophysiology of borderline personality disorder: a model of the role of oxytocin. Am J Psychiatry. 2015 Sep 1;172(9):840-51.

• 摘要

37.  Bertsch K, Schmidinger I, Neumann ID, et al. Reduced plasma oxytocin levels in female patients with borderline personality disorder. Horm Behav. 2013 Mar;63(3):424-9.

• 摘要

38.  Kendler K, Czajkowski N, Tambs K, et al. Dimensional representations of DSM-IV Cluster A personality disorders in a population-based sample of Norwegian twins: a multivariate study. Psychol Med. 2006 Nov;36(11):1583-91.

• 摘要

39.  Tienari P, Wynne LC, Läksy K, et al. Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia. Am J Psychiatry 2003 Sep;160(9):1587-94.

• 摘要

40.  Johnson JG, Cohen P, Chen H, et al. Parenting behaviors associated with risk for offspring personality disorder during adulthood. Arch Gen Psychiatry. 2006 May;63(5):579-87.

• 全文
• 摘要

41.  Helgeland MI, Kjelsberg E, Torgersen S. Continuities between emotional and disruptive behavior disorders in adolescence and personality disorders in adulthood. Am J Psychiatry. 2005 Oct;162(10):1941-7.

• 摘要

42.  Ryder AG, Costa PT, Bagby RM. Evaluation of the SCID-II personality disorder traits for DSM-IV: coherence, discrimination, relations with general personality traits, and functional impairment. J Pers Disord. 2007 Dec;21(6):626-37.

• 摘要

43.  McCrae R, Löckenhoff C, Costa P. A step toward DSM-V: cataloguing personality-related problems in living. Eur J Pers. 2005 Jun;19(4):269-86.

• 全文

44.  Skodol AE, Bender DS. The future of personality disorders in DSM-V? Am J Psychiatry. 2009 Apr;166(4):388-91.

• 摘要

45.  Widiger TA. Assessment of DSM-5 personality disorder. J Pers Assess. 2015 Sep-Oct;97(5):456-66.

• 摘要

46.  Eisen JL, Coles ME, Shea MT, et al. Clarifying the convergence between obsessive compulsive disorder criteria and obsessive compulsive disorder. J Pers Disord. 2006 Jun;20(3):294-305.

• 全文
• 摘要

47.  Huppert JD, Strunk DR, Ledley DR, et al. Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome. Depress Anxiety. 2008;25(5):441-8.

• 摘要

48.  Hahn SR, Thompson KS, Wills TA, et al. The difficult doctor-patient relationship: somatization, personality and psychopathology. J Clin Epidemiol. 1994 Jun;47(6):647-57.

• 摘要

49.  Rost KM, Akins RN, Brown FW, et al. The comorbidity of DSM-III-R personality disorders in somatization disorder. Gen Hosp Psychiatry. 1992 Sep;14(5):322-6.

• 摘要

50.  Joiner T, Kalafat J, Draper J, et al. Establishing standards for the assessment of suicide risk among callers to the National Suicide Prevention Lifeline. Suicide Life Threat Behav. 2007 Jun;37(3):353-65.

• 摘要

51.  Moran P, Leese M, Lee T, et al. Standardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 2003 Sep;183:228-32.

• 摘要

52.  Hesse M, Moran P. Screening for personality disorder with the Standardised Assessment of Personality - Abbreviated Scale (SAPAS): further evidence of concurrent validity. BMC Psychiatry. 2010 Jan 28;10:10.

• 摘要

53.  Gorwood P, Rouillon F, Even C, et al. Treatment response in major depression: effects of personality dysfunction and prior depression. Br J Psychiatry. 2010 Feb;196(2):139-42.

• 摘要

54.  Morse JQ, Pilkonis PA. Screening for personality disorders. J Pers Disord. 2007 Apr;21(2):179-98.

• 摘要

55.  Walters P, Moran P, Choudhury P, et al. Screening for personality disorder: a comparison of personality disorder assessment by patients and informants. Int J Methods Psychiatr Res. 2004;13(1):34-9.

• 摘要

56.  Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994 Dec 14;272(22):1749-56.

• 摘要

57.  Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.

• 全文
• 摘要

58.  Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25.

• 摘要

59.  Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.

• 全文
• 摘要

60.  Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000 Nov;157(11):1873-5.

• 全文
• 摘要

61.  LeFevre ML; US Preventive Services Task Force. Screening for suicide risk in adolescents, adults, and older adults in primary care: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 May 20;160(10):719-26.

• 全文
• 摘要

62.  Whitlock EP, Polen MR, Green CA, et al. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004 Apr 6;140(7):557-68.

• 全文
• 摘要

63.  Balint M. The doctor, his patient, and the illness. New York, NY: International Universities Press; 1957.

64.  Devens M. Personality disorders. Prim Care. 2007 Sep;34(3):623-40.

• 摘要

65.  Zaheer J, Links PS, Liu E. Assessment and emergency management of suicidality in personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):527-43.

• 摘要

66.  Soloff PH, Lynch KG, Kelly TM, et al. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am J Psychiatry. 2000 Apr;157(4):601-8.

• 摘要

67.  Apter A, Bleich A, King RA, et al. Death without warning? A clinical postmortem study of suicide in 43 Israeli adolescent males. Arch Gen Psychiatry. 1993 Feb;50(2):138-42.

• 摘要

68.  Fenton WS, McGlashan TH, Victor BJ, et al. Symptoms, subtype and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry. 1997 Feb;154(2):199-204.

• 摘要

69.  Duggan C, Huband N, Smailagic N, et al. The use of psychological treatments for people with personality disorder: a systematic review of randomized controlled trials. Pers Ment Health. 2007 Nov;1(2):95-125.

• 全文

70.  Paris J. Clinical trials of treatment for personality disorders. Psychiatr Clin North Am. 2008 Sep;31(3):517-26.

• 摘要

71.  Arnevik E, Wilberg T, Urnes Ø, et al. Psychotherapy for personality disorders: 18 months' follow-up of the Ullevål Personality Project. J Pers Disord. 2010 Apr;24(2):188-203.

• 摘要

72.  Hadjipavlou G, Ogrodniczuk JS. Promising psychotherapies for personality disorders. Can J Psychiatry. 2010 Apr;55(4):202-10.

• 摘要

73.  Leichsenring F, Rabung S. Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis. JAMA. 2008 Oct 1;300(13):1551-65.

• 摘要

74.  de Maat S, de Jonghe F, Schoevers R, et al. The effectiveness of long-term psychoanalytic therapy: a systematic review of empirical studies. Harv Rev Psychiatry. 2009;17(1):1-23.

• 摘要

75.  Simon W. Follow-up psychotherapy outcome of patients with dependent, avoidant and obsessive-compulsive personality disorders: a meta-analytic review. Int J Psychiatry Clin Pract. 2009;13(2):153-65.

• 摘要

76.  Gunderson JG. Clinical practice. Borderline personality disorder. N Engl J Med. 2011 May 26;364(21):2037-42.

• 摘要

77.  Madeddu F, Aquaro P, Preti E. Psychotherapy for borderline personality disorder: A review of literature on the efficacy of four manualized treatments [in Italian]. Italian J Psychopathol. 2012;18(3):196-209.

• 全文

78.  Stoffers JM, Völlm BA, Rücker G, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD005652.

• 全文
• 摘要

79.  Gibbon S, Duggan C, Stoffers J, et al. Psychological interventions for antisocial personality disorder. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007668.

• 全文
• 摘要

80.  Armelius BA, Andreassen TH. Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005650.

• 全文
• 摘要

81.  Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.

• 全文
• 摘要

82.  Dimeff LA, Koerner K, eds. Dialectical behavior therapy in clinical practice. New York, NY: The Guilford Press; 2007.

83.  Duggan C, Huband N, Smailagic N, et al. The use of pharmacological treatments for people with personality disorder: a systematic review of randomized controlled trials. Pers Ment Health. 2008 Jul;2(3):119-70.

• 全文

84.  Bateman AW, Gunderson J, Mulder R, et al. Treatment of personality disorder. Lancet. 2015 Feb 21;385(9969):735-43.

• 摘要

85.  Zanarini MC, Frankenburg FR, Hennen J, et al. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004 Nov;161(11):2108-14.

• 摘要

86.  National Institute for Health and Care Excellence. Borderline personality disorder: recognition and management. Jan 2009 [internet publication].

• 全文

87.  Goldberg SC, Schulz SC, Schulz PM, et al. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo. Arch Gen Psychiatry. 1986 Jul;43(7):680-6.

• 摘要

88.  Koenigsberg HW, Reynolds D, Goodman M, et al. Risperidone in the treatment of schizotypal personality disorder. J Clinical Psychiatry. 2003 Jun;64(6):628-34.

• 摘要

89.  Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry. 1984 Nov;141(11):1455-8.

• 摘要

90.  Soloff PH, George A, Nathan RS, et al. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry. 1986 Jul;43(7):691-7.

• 摘要

91.  Markovitz PJ, Calabrese JR, Schulz SC, et al. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry. 1991 Aug;148(8):1064-7.

• 摘要

92.  Jensen HV, Andersen J. An open, noncomparative study of amoxapine in borderline disorders. Acta Psychiatrica Scandinavica. 1989 Jan;79(1):89-93.

• 摘要

93.  Mercer D, Douglass AB, Links PS, et al. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord. 2009 Apr;23(2):156-74.

• 摘要

94.  Ingenhoven T, Lafay P, Rinne T, et al. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry. 2010 Jan;71(1):14-25.

• 摘要

95.  Crawford MJ, Sanatinia R, Barrett B, et al. Lamotrigine for people with borderline personality disorder: a RCT. Health Technol Assess. 2018 Apr;22(17):1-68.

• 全文
• 摘要

96.  Sheard MH, Marini JL, Bridges CI, et al. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry. 1976 Dec;133(12):1409-13.

• 摘要

97.  Barratt ES, Kent TA, Bryant SG, et al. Controlled trial of phenytoin in impulsive aggression. J Clinical Psychopharmacol. 1991 Dec;11(6):388-9.

• 摘要

98.  National Institute for Health and Care Excellence. Antisocial personality disorder: prevention and management. Mar 2013 [internet publication].

• 全文

99.  Loranger AW, Sartorius N, Andreoli A, et al. The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse, and Mental Health Administration international pilot study of personality disorders. Arch Gen Psychiatry. 1994 Mar;51(3):215-24.

• 摘要

100.  Alden LE, Laposa JM, Taylor CT, et al. Avoidant personality disorder: current status and future directions. J Pers Disord. 2002 Feb;16(1):1-29.

• 摘要

101.  Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007;8(4):212-44.

• 全文
• 摘要

102.  Van Ameringen MA, Lane RM, WAlker JR, et al. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry. 2001 Feb;158(2):275-81.

• 摘要

103.  Pande AC, Feltner DE, Jefferson JW, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clinical Psychopharmacol. 2004 Apr;24(2):141-9.

• 摘要

104.  Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol. 1999 Aug;19(4):341-8.

• 摘要

105.  Soloff PH. Symptom-oriented psychopharmacology for personality disorders. J Psych Prac. 1998 Jan;4(1):3-11.

• 全文

106.  Soloff PH. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulse-behavioral dysregulation. Bull Menninger Clin. 1998 Spring;62(2):195-214.

• 摘要

107.  Ripoll LH. Clinical psychopharmacology of borderline personality disorder: an update on the available evidence in light of the Diagnostic and Statistical Manual of Mental Disorders - 5. Curr Opin Psychiatry. 2012 Jan;25(1):52-8.

• 摘要

108.  Bellino S, Bozzatello P, Blandamura A, et al. Antidepressants in the treatment of borderline personality disorder: a review of literature data [in Italian]. J Psychopathol. 2009;15(2):163-76.

• 全文

109.  Kleber HD, Weiss RD, Anton RF Jr, et al; Work Group on Substance Use Disorders. Treatment of patients with substance use disorders: second edition. Am J Psychiatry. 2006 Aug;163(8 Suppl):5-82.

• 摘要

110.  Rudd MD, Mandrusiak M, Joiner Jr TE. The case against no-suicide contracts: the commitment to treatment statement as a practice alternative. J Clin Psychol. 2006 Feb;62(2):243-51.

• 摘要

111.  European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. Mar 2018 [internet publication].

• 全文

112.  Zanarini MC, Frankenburg FR, Hennen J, et al. Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry. 2006 May;163(5):827-32.

• 摘要

113.  Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999 Oct;156(10):1563-9.

• 摘要

114.  Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011 Aug;68(8):827-37.

• 全文
• 摘要

115.  Soloff PH, Fabio A, Kelly TM, et al. High-lethality status in patients with borderline personality disorder. J Pers Disord. 2005 Aug;19(4):386-99.

• 摘要

116.  Oldham JM. Borderline personality disorder and suicidality. Am J Psychiatry. 2006 Jan;163(1):20-6.

• 摘要

117.  McMain S. Effectiveness of psychosocial treatments on suicidality in personality disorders. Can J Psychiatry. 2007 Jun;52(6 Suppl 1):103S-14S.

• 摘要